The abstract is read at the publisher; the summary is JClub's.
Remote ischemic preconditioning reduced contrast-associated acute kidney injury in patients undergoing coronary angiography or percutaneous coronary intervention, with an RR of 0.54 (95% CI 0.45–0.65).
- Why it matters: Prior trials on remote ischemic preconditioning for contrast-associated AKI and short-term cardiac outcomes have been inconsistent, leaving uncertainty about its clinical value in coronary angiography or PCI patients.
- What they did: A systematic review and meta-analysis of 36 randomized controlled trials (10,923 patients) compared remote ischemic preconditioning versus sham or usual care, pooling risk ratios with random-effects models.
- The result: It significantly lowered contrast-associated AKI and probably reduced in-hospital major adverse cardiovascular events (RR 0.51; 95% CI 0.26–0.98), with no differences in dialysis, in-hospital mortality, 30-day mortality, or 30-day MACE.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.